In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu 2/3 receptor antagonist-Reference-Cited by-同舟云学术

In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu 2/3 receptor antagonist

Published:2017-03 Issue: Volume:115 Page:100-114
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Witkin Jeffrey M.,Ornstein Paul L.,Mitch Charles H.,Li Renhua,Smith Stephon C.,Heinz Beverly A.,Wang Xu-Shan,Xiang Chuanxi,Carter Joan H.,Anderson Wesley H.,Li Xia,Broad Lisa M.,Pasqui Francesca,Fitzjohn Stephen M.,Sanger Helen E.,Smith Jodi L.,Catlow John,Swanson Steven,Monn James A.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference105 articles.

1. The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses isolation rearing-induced abnormal behaviors in mice;Ago;J. Pharmacol. Sci.,2012

2. Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice;Ago;Neuropharmacology,2013

3. A role for AMPA receptors in mood disorders;Alt;Biochem. Pharmacol.,2006

4. Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions;Anderson;J. Neurosci.,2007

5. Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats;Attwell;Brain Res.,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development;European Archives of Psychiatry and Clinical Neuroscience;2023-01-30

2. Role of interaction of mGlu2 and 5-HT2A receptors in antipsychotic effects;Pharmacology Biochemistry and Behavior;2022-11

3. Metabotropic Glutamate Receptors Modulate Exocytotic Tau Release and Propagation;Journal of Pharmacology and Experimental Therapeutics;2022-09-18

4. Advances in translating mGlu2 and mGlu3 receptor selective allosteric modulators as breakthrough treatments for affective disorders and alcohol use disorder;Pharmacology Biochemistry and Behavior;2022-09

5. The mGlu7 receptor in schizophrenia - An update and future perspectives;Pharmacology Biochemistry and Behavior;2022-07